Back to search

Switzerland· 61207001

Neurexan, Tropfen zum Einnehmen

A medicinal product containing passiflora incarnata (hab) d2, avena sativa (hab) d2, coffea arabica (hab) d12, zincum isovalerianicum (hab) d4 (hab 5a), registered in Switzerland by ebi-pharm ag and dispensed under Swissmedic category D.

Cat D (Swissmedic)

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedNeurexan, Tropfen zum EinnehmenATC—REGISTER NO.61207001PACKS LISTED0CHECKEDSeptember 12, 2026

The record

At a glance

Swissmedic (Switzerland)
Active substance
passiflora incarnata (HAB) D2, avena sativa (HAB) D2, coffea arabica (HAB) D12, zincum isovalerianicum (HAB) D4 (HAB 5a)
Manufacturer
ebi-pharm ag
Country
Switzerland (CH)
ATC code
—
Swissmedic category
D
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e6ed89ef-394a-4eb6-a6dd-4d76cb71801d
GET /v1/drugs/e6ed89ef-394a-4eb6-a6dd-4d76cb71801d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Homöopathische Arzneimittel"
}

See everything about passiflora incarnata (hab) d2, avena sativa (hab) d2, coffea arabica (hab) d12, zincum isovalerianicum (hab) d4 (hab 5a).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.